APRE
Price
$1.61
Change
-$0.04 (-2.42%)
Updated
May 9, 12:04 PM (EDT)
Capitalization
9.28M
PRQR
Price
$1.55
Change
-$0.02 (-1.27%)
Updated
May 8 closing price
Capitalization
165.18M
83 days until earnings call
Ad is loading...

APRE vs PRQR

Header iconAPRE vs PRQR Comparison
Open Charts APRE vs PRQRBanner chart's image
Aprea Therapeutics
Price$1.61
Change-$0.04 (-2.42%)
Volume$403
Capitalization9.28M
ProQR Therapeutics
Price$1.55
Change-$0.02 (-1.27%)
Volume$438.6K
Capitalization165.18M
APRE vs PRQR Comparison Chart
Loading...
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APRE vs. PRQR commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APRE is a StrongBuy and PRQR is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (APRE: $1.65 vs. PRQR: $1.55)
Brand notoriety: APRE and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APRE: 19% vs. PRQR: 63%
Market capitalization -- APRE: $9.28M vs. PRQR: $165.18M
APRE [@Biotechnology] is valued at $9.28M. PRQR’s [@Biotechnology] market capitalization is $165.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APRE’s FA Score shows that 2 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • APRE’s FA Score: 2 green, 3 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, APRE is a better buy in the long-term than PRQR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APRE’s TA Score shows that 4 TA indicator(s) are bullish while PRQR’s TA Score has 6 bullish TA indicator(s).

  • APRE’s TA Score: 4 bullish, 4 bearish.
  • PRQR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRQR is a better buy in the short-term than APRE.

Price Growth

APRE (@Biotechnology) experienced а -8.63% price change this week, while PRQR (@Biotechnology) price change was -9.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.07%. For the same industry, the average monthly price growth was +11.11%, and the average quarterly price growth was -13.36%.

Reported Earning Dates

APRE is expected to report earnings on Mar 25, 2025.

PRQR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-5.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($165M) has a higher market cap than APRE($9.28M). PRQR YTD gains are higher at: -41.509 vs. APRE (-49.733). APRE has higher annual earnings (EBITDA): -14.75M vs. PRQR (-24.12M). PRQR has more cash in the bank: 149M vs. APRE (26.2M). APRE has less debt than PRQR: APRE (0) vs PRQR (17.2M). PRQR has higher revenues than APRE: PRQR (18.9M) vs APRE (0).
APREPRQRAPRE / PRQR
Capitalization9.28M165M6%
EBITDA-14.75M-24.12M61%
Gain YTD-49.733-41.509120%
P/E RatioN/AN/A-
Revenue018.9M-
Total Cash26.2M149M18%
Total Debt017.2M-
FUNDAMENTALS RATINGS
PRQR: Fundamental Ratings
PRQR
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APREPRQR
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDTGX84.59N/A
N/A
Fidelity Advisor Consumer Staples M
VBCVX14.31N/A
N/A
VALIC Company I Systematic Value
FCDIX34.16N/A
N/A
Fidelity Advisor Stock Selector Sm Cp I
FWMNX16.02N/A
N/A
Fidelity Advisor Women's Leadership I
EEMIX8.39N/A
N/A
MFS Emerging Markets Equity Research I

APRE and

Correlation & Price change

A.I.dvisor tells us that APRE and ATOS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APRE and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APRE
1D Price
Change %
APRE100%
-1.56%
ATOS - APRE
32%
Poorly correlated
-0.28%
KPRX - APRE
31%
Poorly correlated
-6.87%
NKTR - APRE
29%
Poorly correlated
+2.20%
PRQR - APRE
29%
Poorly correlated
-1.27%
NTLA - APRE
28%
Poorly correlated
+13.58%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with KRRO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-1.27%
KRRO - PRQR
60%
Loosely correlated
+10.55%
WVE - PRQR
58%
Loosely correlated
+0.77%
ATNF - PRQR
54%
Loosely correlated
-0.64%
ENVB - PRQR
43%
Loosely correlated
+4.96%
RCKT - PRQR
37%
Loosely correlated
+11.57%
More